NeuroPace Current Ratio 2020-2025 | NPCE
NeuroPace current ratio from 2020 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| NeuroPace Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-06-30 | $0.09B | $0.02B | 5.47 |
| 2025-03-31 | $0.10B | $0.02B | 6.63 |
| 2024-12-31 | $0.08B | $0.02B | 5.37 |
| 2024-09-30 | $0.08B | $0.02B | 5.59 |
| 2024-06-30 | $0.08B | $0.01B | 6.38 |
| 2024-03-31 | $0.08B | $0.01B | 6.43 |
| 2023-12-31 | $0.09B | $0.02B | 5.71 |
| 2023-09-30 | $0.08B | $0.01B | 6.55 |
| 2023-06-30 | $0.09B | $0.01B | 7.52 |
| 2023-03-31 | $0.09B | $0.01B | 9.13 |
| 2022-12-31 | $0.10B | $0.01B | 8.90 |
| 2022-09-30 | $0.10B | $0.01B | 11.08 |
| 2022-06-30 | $0.11B | $0.01B | 9.86 |
| 2022-03-31 | $0.12B | $0.01B | 10.15 |
| 2021-12-31 | $0.13B | $0.01B | 14.28 |
| 2021-09-30 | $0.14B | $0.01B | 16.20 |
| 2021-06-30 | $0.15B | $0.01B | 19.24 |
| 2021-03-31 | $0.05B | $0.01B | 4.36 |
| 2020-12-31 | $0.06B | $0.01B | 5.69 |
| 2020-09-30 | $0.00B | 0.00 | |
| 2020-06-30 | $0.00B | 0.00 | |
| 2020-03-31 | $0.00B | 0.00 | |
| 2019-12-31 | $0.02B | $0.08B | 0.27 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.294B | $0.080B |
| NeuroPace Inc. is a commercial-stage medical device company. It is focused on developing products to treat and transform the lives of patients suffering from epilepsy. NeuroPace Inc. is based in MOUNTAIN VIEW, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.320B | 22.30 |
| Intuitive Surgical (ISRG) | United States | $168.896B | 70.01 |
| IDEXX Laboratories (IDXX) | United States | $51.272B | 53.36 |
| Edwards Lifesciences (EW) | United States | $47.496B | 31.48 |
| Alcon (ALC) | Switzerland | $40.130B | 26.94 |
| IQVIA Holdings (IQV) | United States | $32.096B | 18.14 |
| DexCom (DXCM) | United States | $29.953B | 44.93 |
| Mettler-Toledo (MTD) | United States | $26.475B | 31.42 |
| STERIS (STE) | Ireland | $24.522B | 26.10 |
| Waters (WAT) | United States | $17.538B | 24.09 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.006B | 0.00 |
| Hologic (HOLX) | United States | $14.842B | 16.08 |
| Penumbra (PEN) | United States | $10.410B | 76.05 |
| Globus Medical (GMED) | United States | $8.307B | 19.16 |
| Sysmex ADR (SSMXY) | Japan | $8.057B | 25.60 |
| Masimo (MASI) | United States | $7.741B | 26.05 |
| Teleflex (TFX) | United States | $5.723B | 9.24 |
| Glaukos (GKOS) | United States | $5.455B | 0.00 |
| TransMedics (TMDX) | United States | $4.002B | 60.82 |
| Integer Holdings (ITGR) | United States | $3.786B | 18.89 |
| LivaNova (LIVN) | United Kingdom | $3.084B | 17.65 |
| Alphatec Holdings (ATEC) | United States | $2.394B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.270B | 0.00 |
| Veracyte (VCYT) | United States | $2.251B | 31.10 |
| Artivion (AORT) | United States | $2.064B | 104.14 |
| Nihon Kohden (NHNKY) | Japan | $1.907B | 22.76 |
| Elekta AB (EKTAY) | Sweden | $1.887B | 17.66 |
| Integra LifeSciences Holdings (IART) | United States | $1.159B | 6.64 |
| OPKO Health (OPK) | United States | $1.127B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.066B | 0.00 |
| IRadimed (IRMD) | United States | $0.939B | 45.59 |
| Tandem Diabetes Care (TNDM) | United States | $0.828B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.825B | 0.00 |
| AxoGen (AXGN) | United States | $0.743B | 0.00 |
| SiBone (SIBN) | United States | $0.716B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.586B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.551B | 9.73 |
| OrthoPediatrics (KIDS) | United States | $0.542B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.469B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.452B | 3.63 |
| AngioDynamics (ANGO) | United States | $0.407B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.399B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.383B | 91.17 |
| Mesa Laboratories (MLAB) | United States | $0.378B | 9.62 |
| RxSight (RXST) | United States | $0.350B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.302B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.293B | 20.23 |
| Spectral Diagnostics (EDTXF) | Canada | $0.293B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.286B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.229B | 0.00 |
| 908 Devices (MASS) | United States | $0.226B | 0.00 |
| Neuronetics (STIM) | United States | $0.222B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.222B | 0.00 |
| Inogen (INGN) | United States | $0.214B | 0.00 |
| CVRx (CVRX) | United States | $0.198B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.185B | 0.00 |
| Accuray (ARAY) | United States | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.150B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.137B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.132B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.113B | 0.00 |
| InspireMD (NSPR) | United States | $0.102B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.098B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.088B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.071B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.059B | 0.00 |
| Spectral AI (MDAI) | United States | $0.056B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.039B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.025B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.31 |